Postdoctoral Fellow
Toshi Takagi obtained his MD from Kyushu University and his Phd at University of Tokyo. He did postdoctoral work in the Buratowski lab from 1996 to 2000 with support from the American Cancer Society. In the process of identifying the first higher eukaryotic capping enzyme gene, he discovered a new class of RNA phosphatases that resembled protein tyrosine phosphatases. Since leaving the lab, he has been a senior research scientist at Shionogi BioResearch, Merck, and Rosetta. After many years running the high throughput drug screening at the Sloan-Kettering Institute, Toshi recently moved to Poland to become the Director of High-Throughput Screening at Captor Therapeutics. Toshi's LinkedIn Profile.